Physician profile
Laurence Cane
NPI 1003954553
$8,785.26
in general payments reported to CMS, 2019-2025
25 companies · $1,217 in 2025
The $1,217 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,365 · 2020: $117 · 2021: $2,580 · 2022: $1,055 · 2023: $1,720 · 2024: $730 · 2025: $1,217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,683 · Travel and Lodging: $985.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,682.88 |
| Travel and Lodging | $984.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $2,015.78 | 2019-2023 | Portfolio |
| Stryker Corporation | $1,999.54 | 2021-2025 | Prostep, Augment Injectable, Prostep Mica |
| Peerless Surgical INC. | $1,897.75 | 2021-2024 | |
| Orthofix Medical, INC. | $606.21 | 2022-2025 | Physio-Stim, Accelstim |
| Arthrex, INC. | $462.48 | 2023 | |
| Smith+Nephew, INC. | $406.97 | 2019-2024 | Collagenase Santyl, Renasys Touch, Pico 7 |
| Paratek Pharmaceuticals, INC. | $227.50 | 2022-2023 | Nuzyra |
| Imperative Care, INC | $183.92 | 2025 | Prodigy Catheter |
| Organogenesis INC. | $128.10 | 2021-2022 | |
| Convatec INC. | $124.91 | 2023 | |
| Abbvie INC. | $123.99 | 2024 | |
| Depuy Synthes Sales INC. | $114.55 | 2023-2024 | Chia Percpasser, Cor, Motoband |
| Next Science LLC | $83.53 | 2023-2024 | Blastx, Xperience, Surgx |
| Tactile Systems Technology INC | $80.34 | 2024-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Averitas Pharma INC. | $54.99 | 2024-2025 | Qutenza |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $46.19 | 2023 | |
| Acera Surgical, INC. | $45.45 | 2023 | Restrata Wound Matrix |
| Wright Medical Technology, INC. | $41.48 | 2019 | |
| Electronic Waveform Lab, INC. | $27.65 | 2025 | |
| Medtronic, INC. | $23.23 | 2022 | |
| Globus Medical, INC. | $23.07 | 2025 | Omnia |
| Pacira Pharmaceuticals Incorporated | $19.69 | 2024 | Exparel, Iovera |
| Triad Life Sciences INC. | $17.03 | 2022 | |
| Horizon Therapeutics Plc | $16.81 | 2022 | |
| Kerecis Limited | $14.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laurence Cane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.